Drug Profile
Volinanserin
Alternative Names: 100,907; M 100907; MDL 100907Latest Information Update: 13 Mar 2009
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Class Piperidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Insomnia; Schizophrenia